CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Emphasys Endobronchial Valve and procedureprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00129584
NCT00129584Phase 3Completed

Endobronchial Valve for Emphysema Palliation Trial (VENT)

Emphasys Medical·interventional·Posted Aug 12, 2005·Updated Aug 18, 2009

In Brief

A Phase 3 clinical trial evaluating Emphasys Endobronchial Valve and procedure for Chronic Obstructive Pulmonary Disease and Emphysema. Completed.

Detailed Summary

The purpose of this study is to assess the safety and efficacy of the Emphasys Endobronchial Valve (EBV) and procedure (with pulmonary rehabilitation) compared to optimal medical management (with pulmonary rehabilitation) in patients with heterogeneous emphysema.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 12, 2005
Enrollment StartJan 1, 2004
TodayJul 2, 2026
Posted 20.9 years ago

Interventions

Emphasys Endobronchial Valve and procedureprocedure